Cargando…

A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease

INTRODUCTION: Programmed cell death protein 1 (PD-1), an immune checkpoint molecule, has recently been recognized as a predictive and prognostic biomarker in several malignant tumors, but its diagnostic value remains largely unknown. We aimed to investigate the differential diagnostic efficiency of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Chao, Sun, Bing, Xu, Bin, Meng, Xiangying, Li, Lan, Cong, Yang, Liu, Jiannan, Wang, Qian, Xuan, Liang, Song, Qibin, Wu, Shikai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027692/ https://www.ncbi.nlm.nih.gov/pubmed/29983594 http://dx.doi.org/10.2147/CMAR.S160452

Ejemplares similares

Albumin/globulin ratio is negatively correlated with PD-1 and CD25 mRNA levels in breast cancer patients
por: Liu, Chao, et al.
Publicado: (2018)

Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two cases
por: Xuan, Liang, et al.
Publicado: (2020)

IL-15/IL-15Rα Heterodimeric Complex as Cancer Immunotherapy in Murine Breast Cancer Models
por: Guo, Siqi, et al.
Publicado: (2021)

Vaccination with Tumor Cells Expressing IL-15 and IL-15Rα Inhibit Murine Breast and Prostate Cancer
por: Morris, John C., et al.
Publicado: (2014)

IL-15/IL-15Rα in SJS/TEN: Relevant Expression of IL15 and IL15RA in Affected Skin
por: Bellón, Teresa, et al.
Publicado: (2022)

Density of bone metastatic lesions increases after radiotherapy in patients with breast cancer
por: Wang, Qian, et al.
Publicado: (2019)

Predictive Value of Lymphocyte-Related Blood Parameters at the Time Point of Lymphocyte Nadir During Radiotherapy in Breast Cancer
por: Liu, Jiannan, et al.
Publicado: (2020)

IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas
por: Di Napoli, Arianna, et al.
Publicado: (2020)

Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell
por: Widowati, Wahyu, et al.
Publicado: (2020)

Expression analysis of cytokines IL-5, IL-6, IL-8, IL-17 and VEGF in breast cancer patients
por: Liu, Gang, et al.
Publicado: (2022)

An activation-induced IL-15 isoform is a natural antagonist for IL-15 function
por: Zhao, Lei, et al.
Publicado: (2016)

Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
por: Wang, Gangping, et al.
Publicado: (2014)

Evaluation of the clinical molecule anti-human-PD-L1/IL-15 KD033 in the human-PD-1/PD-L1-expressing murine model demonstrates PD-L1 targeting of IL-15 in vivo
por: Martomo, Stella A., et al.
Publicado: (2022)

IL-2, IL-15 and IL-21 expand T cells for targeted adoptive therapy
por: Liu, Zhenjiang, et al.
Publicado: (2015)

Preclinical evaluation of IAP0971, a novel immunocytokine that binds specifically to PD1 and fuses IL15/IL15Rα complex
por: Chen, Jihong, et al.
Publicado: (2022)

A four-gene signature for prognosis in breast cancer patients with hypermethylated IL15RA
por: Yang, Hui, et al.
Publicado: (2019)

Outcomes and toxicity of stereotactic body radiation therapy for advanced stage ultra‐central non‐small cell lung cancer
por: Cong, Yang, et al.
Publicado: (2019)

A nomogram for predicting survival in patients with breast cancer brain metastasis
por: Huang, Zhou, et al.
Publicado: (2018)

Interleukin-15 (IL-15) and IL-15 receptor alpha fusion protein enhances antitumor activity of myxoma virus
por: Tosic, Vesna, et al.
Publicado: (2013)

IL-22 promotes tumor growth of breast cancer cells in mice
por: Zhang, Ying, et al.
Publicado: (2020)

Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
por: Knudson, Karin M., et al.
Publicado: (2019)

Electrotransfer of IL-15/IL-15Rα complex for the treatment of established melanoma
por: Shirley, Shawna, et al.
Publicado: (2015)

Electrotransfer of IL-15/IL-15Rα Complex for the Treatment of Established Melanoma
por: Shirley, Shawna A., et al.
Publicado: (2020)

Decreased levels of circulating cytokines VEGF, TNF-β and IL-15 indicate PD-L1 overexpression in tumours of primary breast cancer patients
por: Cierna, Zuzana, et al.
Publicado: (2021)

Immunomodulation with IL-7 and IL-15 in HIV-1 infection
por: Gunst, Jesper D., et al.
Publicado: (2023)

Computational Pathology to Discriminate Benign from Malignant Intraductal Proliferations of the Breast
por: Dong, Fei, et al.
Publicado: (2014)

Discrimination of breast cancer from benign tumours using Raman spectroscopy
por: Lyng, Fiona M., et al.
Publicado: (2019)

Co-expression IL-15 receptor alpha with IL-15 reduces toxicity via limiting IL-15 systemic exposure during CAR-T immunotherapy
por: Zhang, Ying, et al.
Publicado: (2022)

Role of immune-related lncRNAs--PRKCQ-AS1 and EGOT in the regulation of IL-1β, IL-6 and IL-8 expression in human gingival fibroblasts with TNF-α stimulation
por: Zhao, Quanquan, et al.
Publicado: (2023)

Association of IL10, IL10RA, and IL10RB Polymorphisms with Benign Prostate Hyperplasia in Korean Population
por: Yoo, Koo Han, et al.
Publicado: (2011)

Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation
por: Zhang, Xian, et al.
Publicado: (2022)

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
por: Kim, Peter S., et al.
Publicado: (2016)

IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer
por: Khodadadi, Ali, et al.
Publicado: (2014)

IL-15 and IL15RA in Osteoarthritis: Association With Symptoms and Protease Production, but Not Structural Severity
por: Warner, Sophie C., et al.
Publicado: (2020)

IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
por: Battram, Anthony M., et al.
Publicado: (2021)

Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs
por: Neves, Fabiana, et al.
Publicado: (2015)

IL15N72D superagonist/IL15Rα-Fc fusion complex (ALT-803) exhibits anti-metastatic activity in murine breast tumor model
por: Kim, Peter S, et al.
Publicado: (2015)

Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes
por: Dong, Wen, et al.
Publicado: (2016)

Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
por: Yang, Ying, et al.
Publicado: (2020)

Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease
por: Shaw, Victoria E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8ak025p91jvonnbe7dlg0go1ln